{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:48:06Z","timestamp":1761490086800,"version":"3.37.3"},"reference-count":21,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In 1999, invasive meningococcal disease was hyperendemic in Ireland at 14.75\/100\u2005000 population, with 60% group B and 30% group C diseases. National sepsis guidelines and meningococcal C vaccines were introduced in 2000. Despite a spontaneous decline in group B infection, invasive meningococcal disease remains a leading cause of sepsis. This study characterises the epidemiology of invasive meningococcal disease in children in Ireland since the introduction of meningococcal C vaccine and reviews its clinical presentation, hospital course and outcome in anticipation of meningococcal B vaccine introduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>National surveillance data were obtained from the Health Protection Surveillance Centre. A retrospective study of all meningococcal cases at two tertiary paediatric hospitals was conducted from 2001 to 2011. Records were reviewed using a standardised assessment tool. A study of 407 meningococcal cases published in 2002 provided comparative data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1820 cases &lt;19\u2005years of age notified nationally, 382 (21%) cases attended a study hospital; 94% group B, 3% group C, 225 (59%) male, median age 5\u2005years (range 0.1\u201318). Fever was absent at presentation in 18%. Fifteen patients (3.6%) died. 221 (61%) were admitted to paediatric intensive care units (PICU). Permanent sequelae occurred in 9.4%. Compared with the historical cohort, there were differences in presentation, an increase in PICU interventions, but no significant decline in morbidity or mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Despite the meningococcal C vaccination campaign, invasive meningococcal disease continues to cause serious morbidity and claim lives. Group B infections remain dominant. As children who die often present with fulminant disease, preventive strategies including use of meningococcal B vaccine are needed to avert death and sequelae.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2015-310215","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T02:39:34Z","timestamp":1472265574000},"page":"1125-1129","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Invasive meningococcal disease in children in Ireland, 2001\u20132011"],"prefix":"10.1136","volume":"101","author":[{"given":"Cilian","family":"\u00d3 Maoldomhnaigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-1966","authenticated-orcid":false,"given":"Patrick","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cafferkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina M","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"key":"key-10.1136\/archdischild-2015-310215-1","unstructured":"Epidemiology of Meningococcal Disease in Ireland, 1999\/2000\u2014Epi-Insight, Volume 1, Issue 4, September 2000. hspc.ie (accessed 14 Jun 2015)."},{"key":"key-10.1136\/archdischild-2015-310215-2","first-page":"29","article-title":"Meningococcal disease in Ireland since the introduction of meningococcal serogroup C conjugate vaccination","volume":"8","author":"Fitzgerald","year":"2004","journal-title":"Eurosurveillance"},{"key":"key-10.1136\/archdischild-2015-310215-3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03405553","article-title":"Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go?","volume":"101","author":"White","year":"2010","journal-title":"Can J Public Health"},{"issue":"(Suppl 2)","key":"key-10.1136\/archdischild-2015-310215-4","first-page":"B20","article-title":"Meningococcal C conjugate vaccine: the experience in England and Wales","volume":"27","author":"Campbell","year":"2009"},{"key":"key-10.1136\/archdischild-2015-310215-5","first-page":"227","article-title":"Reduction in invasive meningococcal disease in Queensland: a success for immunisation","volume":"31","author":"Slinko","year":"2007","journal-title":"Commun Dis Intell"},{"key":"key-10.1136\/archdischild-2015-310215-6","unstructured":"http:\/\/www.hpsc.ie\/A-Z\/VaccinePreventable\/BacterialMeningitis\/Publications\/AnnualReports\/MeningococcalDiseaseAnnualReports (accessed May 2016)."},{"key":"key-10.1136\/archdischild-2015-310215-7","unstructured":"Working group on bacterial meningitis and related conditions 1999. http:\/\/www.emed.ie\/Neurological\/_img\/meningfn99.pdf (accessed 19 Jun 2015)."},{"key":"key-10.1136\/archdischild-2015-310215-8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/adc.80.3.290","article-title":"Emergency management of meningococcal disease","volume":"80","author":"Pollard","year":"1999","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2015-310215-9","unstructured":"NICE guideline. Bacterial meningitis and meningococcal septicaemia. https:\/\/www.nice.org.uk\/guidance\/cg102 (accessed 15 Jun 2015)."},{"key":"key-10.1136\/archdischild-2015-310215-10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"key-10.1136\/archdischild-2015-310215-11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/340050","article-title":"Influence of serogroup on the presentation, course and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995\u20132000","volume":"34","author":"Healy","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2015-310215-12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1073\/pnas.94.1.271","article-title":"Capsule switching of Neisseria meningitidis","volume":"94","author":"Swartley","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/archdischild-2015-310215-13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/INF.0b013e318241f824","article-title":"The impact of meningococcal polymerase chain reaction testing on laboratory confirmation of invasive meningococcal disease","volume":"31","author":"Drew","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/archdischild-2015-310215-14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1542\/peds.2010-3852","article-title":"Fever and antipyretic use in children","volume":"127","author":"Sullivan","year":"2011","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2015-310215-15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the meningococcal reference unit","volume":"55","author":"Gray","year":"2006","journal-title":"J Med Microbiol"},{"key":"key-10.1136\/archdischild-2015-310215-16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jinf.2008.10.009","article-title":"Hospital admissions for meningococcal infection in Spain (1997\u20132005)","volume":"58","author":"Montero","year":"2009","journal-title":"J Infect"},{"key":"key-10.1136\/archdischild-2015-310215-17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2015-310215-18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-6976.2006.00060.x","article-title":"A surveillance network for meningococcal disease in Europe","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"key-10.1136\/archdischild-2015-310215-19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/archdischild-2015-310215-20","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1093\/cid\/civ028","article-title":"Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study","volume":"60","author":"Sadarangani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2015-310215-21","doi-asserted-by":"crossref","first-page":"e71943","DOI":"10.1371\/journal.pone.0071943","article-title":"A decade of invasive meningococcal disease surveillance in Poland","volume":"8","author":"Skoczy\u0144ska","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2015-310215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:59:27Z","timestamp":1601117967000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2015-310215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,11,18]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1136\/archdischild-2015-310215"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2015-310215","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"type":"print","value":"0003-9888"},{"type":"electronic","value":"1468-2044"}],"subject":[],"published":{"date-parts":[[2016,8,26]]}}}